Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNAP -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (109)	7/18/2001 10:48:13 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 124

The Looney Brothers, together with some consulting group that had it's head in non-sunshine territory, recently predicted that biotech and pharma would encounter a higher frequency of failures. The logic was that new targets -- derived from genomics -- would not be as "drugable" as the old faithfuls. It's a shame to see the waters being tested at a company like SNAP? There's no room in the business plan for any more extravagant dead ends. Market cap is $60M, so there's lots of room for unabashed celebration, given any success. I don't know anyone who isn't pulling for this company.